Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)
International Journal of Radiology and Imaging Technology · 18.02.2021 · 7 (1)
DOI: 10.23937/2572-3235.1510073 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiology and Imaging Technology, online erschienen am 18.02.2021. Verfasst von Burzynski Stanislaw R und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Long-term survival in Diffuse Intrinsic Pontine Glioma (DIPG) is very rare. The purpose of this report is to detail the early (1988) use of IV Antineoplaston therapy (ANP {A-10 + AS2-1}) and its efficacy in DIPG while presenting the 27.7-year survival of a 36-year-old patient treated with ANP for progressive DIPG.
Zitieren
APA
R, B. S., Tomasz, J., S, B. G., & Samuel, B. (2021). Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG). International Journal of Radiology and Imaging Technology, 7(1). https://doi.org/10.23937/2572-3235.1510073
Vancouver
R BS, Tomasz J, S BG, Samuel B. Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG). International Journal of Radiology and Imaging Technology. 2021;7(1). doi:10.23937/2572-3235.1510073
BibTeX
@article{R2021,
author = {R, Burzynski Stanislaw and Tomasz, Janicki and S, Burzynski Gregory and Samuel, Beenken},
title = {Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)},
journal = {International Journal of Radiology and Imaging Technology},
year = {2021},
volume = {7},
number = {1},
doi = {10.23937/2572-3235.1510073}
}
EUVIMED